A Study of the Effects of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Public ClinicalTrials.gov record NCT06436183. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 2a, Multicenter, Randomized, Double-blind, 16-week Placebo-controlled Study With an Open Label Extension to Evaluate the Efficacy and Safety of Camoteskimab in Adults With Moderate to Severe Atopic Dermatitis
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a Phase 2a, multicenter, randomized, double-blind, placebo-controlled study with an open-label extension to evaluate the efficacy and safety of camoteskimab in adults with moderate to severe AD.
Study identification
- NCT ID
- NCT06436183
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 62 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 1, 2024 (Actual)
- Primary completion
- Mar 26, 2025 (Actual)
- Completion
- Aug 12, 2025 (Actual)
- Last update posted
- Sep 18, 2025
2024 – 2025
United States locations
- U.S. sites
- 30
- U.S. states
- 13
- U.S. cities
- 26
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Medical Dermatology Specialists, PC/US Dermatology Partners | Phoenix | Arizona | 85006 | — |
| California Dermatology & Clinical Research Institute | Encinitas | California | 92024 | — |
| First OC Dermatology Research, Inc. | Fountain Valley | California | 92708 | — |
| Center for Dermatology Clinical Research, Inc. | Fremont | California | 94538 | — |
| California Allergy and Asthma Medical Group | Los Angeles | California | 90025 | — |
| University of California Los Angeles Dermatology | Los Angeles | California | 90095 | — |
| Amicis Research Center (Northridge) | Northridge | California | 91324 | — |
| Cura Clinical Research | Oxnard | California | 93030 | — |
| VASDHS - Veterans Affairs San Diego Medical Center | San Diego | California | 92161 | — |
| Clinical Sciences Institute | Santa Monica | California | 90404 | — |
| Renaissance Research and Medical Group | Cape Coral | Florida | 33991 | — |
| D&H National Research Centers, Inc. | Miami | Florida | 33155 | — |
| Avita Clinical Research - Dermatology | Tampa | Florida | 33613 | — |
| Sneeze, Wheeze & Itch Associates, LLC | Normal | Illinois | 61761 | — |
| Dawes Fretzin Clinical Research | Indianapolis | Indiana | 46250 | — |
| Skin Sciences, PLLC | Louisville | Kentucky | 40217 | — |
| Owensboro Dermatology Associates | Owensboro | Kentucky | 42303 | — |
| Revival Research Institute | Troy | Michigan | 48084 | — |
| Somerset Skin Centre | Troy | Michigan | 48084 | — |
| Michigan Dermatology Institute | Waterford | Michigan | 28329 | — |
| Advanced Dermatology and Skin Cancer Center - Saint Joseph | Saint Joseph | Missouri | 64506 | — |
| Skin Specialists PC | Omaha | Nebraska | 68144 | — |
| M3 Wake Research, Inc. | Raleigh | North Carolina | 27612 | — |
| ObjectiveHealth-The Skin Surgery Center for Clinical Research | Winston-Salem | North Carolina | 27103 | — |
| Central Sooner Research | Oklahoma City | Oklahoma | 73071 | — |
| Unity Clinical Research - Dermatology | Oklahoma City | Oklahoma | 73118 | — |
| Paddington Testing Co. Inc | Philadelphia | Pennsylvania | 19103 | — |
| Rodgers Dermatology | Frisco | Texas | 75034 | — |
| Center for Clinical Studies | Houston | Texas | 77004 | — |
| Clinical Trial Network | Houston | Texas | 77074 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT06436183, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2025 · Synced Oct 27, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT06436183 live on ClinicalTrials.gov.